APA (7th ed.) Citation

Brand, B., Gruppo, R., Wynn, T. T., Griskevicius, L., Lopez Fernandez, M. F., Chapman, M., . . . Abbuehl, B. E. (2016). Efficacy and safety of pegylated full-length recombinant factor VIII with extended half-life for perioperative haemostasis in haemophilia A patients. Haemophilia : the official journal of the World Federation of Hemophilia, 22(4), e251-e258. https://doi.org/10.1111/hae.12963

Chicago Style (17th ed.) Citation

Brand, B., R. Gruppo, T. T. Wynn, L. Griskevicius, M. F. Lopez Fernandez, M. Chapman, T. Dvorak, B. G. Pavlova, and B. E. Abbuehl. "Efficacy and Safety of Pegylated Full-length Recombinant Factor VIII with Extended Half-life for Perioperative Haemostasis in Haemophilia A Patients." Haemophilia : The Official Journal of the World Federation of Hemophilia 22, no. 4 (2016): e251-e258. https://doi.org/10.1111/hae.12963.

MLA (9th ed.) Citation

Brand, B., et al. "Efficacy and Safety of Pegylated Full-length Recombinant Factor VIII with Extended Half-life for Perioperative Haemostasis in Haemophilia A Patients." Haemophilia : The Official Journal of the World Federation of Hemophilia, vol. 22, no. 4, 2016, pp. e251-e258, https://doi.org/10.1111/hae.12963.